14 Years Ago Today, The Giants and Jets Faced Off...and Put One Team...
Four Years Ago, Some Patriot Dropped an Epic Line on a Call With...
DK Metcalf Just Lost a Lot of Money for Punching a Detroit Lion's...
Merry Christmas, Over a Million More Files Potentially Related to the Epstein Case...
Supreme Court Ruled on Trump's Use of National Guard In This Blue State
2025 Media Malpractice Recognized With the Heckler Awards Pt. 2 — The Individual...
Bari Weiss Is Everything Today’s Journalists Hate
Another Left-Wing Judge Just Decided He's Got More Authority Than President Trump
Despite No Evidence, This USAID Cuts Narrative Has Taken Hold
Popular Neo-Nazi to Campaign Against Vivek Ramaswamy in Ohio Gubernatorial Race
Stephen Miller Blasts CBS for Sympathizing With Criminal Illegal Immigrants
Federal Judge Blocks California Policy Forcing Schools to Hide Gender Transitions From Par...
98 Minnesota Mayors Warn of Fiscal Fallout After State Spends $18 Billion Surplus
ICE Agents Fired at Incoming Van in Maryland
Federal Judge Rules That Michigan Cannot Disrupt International Line 5 Pipeline
Tipsheet

Trump Announces Next HHS Nominee, Dems Scrutinize His Former Employment

President Trump aims to fill the role of Health and Human Services Secretary, vacant since Tom Price resigned in lieu of reports about his questionable travel records.

Advertisement

In a tweet posted Monday morning, Trump said he has his new guy.

Azar worked at the pharmaceutical company Eli Lilly for ten years until leaving this past January. That bout of employment is worrisome for some Senate Democrats. Sen. Ron Wyden (OR), for instance, spoke for many of his colleagues when he wondered how Azar could faithfully work to bring down prescription drug prices given his former employment. 

A civil rights lawyer even did some digging to find that Eli Lilly had been accused of driving up the cost of insulin.

Advertisement

Azar, who currently works for a consulting firm, worked as the HHS general counsel from 2001 to 2005 in the George W. Bush administration. His former colleagues note that Azar's work on regulatory reform could be beneficial for an administration trying to undo Obamacare (so far a failed effort.)

Azar served as HHS’s No. 2 under Secretary Mike Leavitt, who said he asked Azar to oversee the department’s regulatory process.

“He understands the process and he knows the levers and how you make it work and where the potential roadblocks are,” Leavitt said. “I think he would be of particular value given the fact that ... so far a repeal bill has not occurred and they’re going to need to make their imprint on existing laws through replacing the ideology underpinning it.”

Democrats like Wyden, however, expect Azar to "faithfully implement" the Affordable Care Act. 

Azar needs 51 votes for confirmation.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos